UK regulator authorises Pfizer-BioNTech shot for JN.1 COVID variant-March 2024-www.financetom.com

UK regulator authorises Pfizer-BioNTech shot for JN.1 COVID variant

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

UK regulator authorises Pfizer-BioNTech shot for JN.1 COVID variant

Jul 24, 2024 9:27 AM

July 24 (Reuters) - Britain's health regulator said on

Wednesday it has authorised Pfizer ( PFE ) and BioNTech's

updated COVID-19 vaccine that targets the JN.1

subvariant of the coronavirus for use in infants, children and

adults.

Previous page： Trump visa curbs push U.S. firms to consider shifting more work to India Next page： COLUMN-Big Oil is long-term bullish despite short-term gloom: Bousso

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Trump visa curbs push U.S. firms to consider shifting more work to India

Sep 29, 2025

* Visa curbs force U.S. firms to rethink labour strategies * Work tied to AI, cybersecurity could shift to India * GCCs maturing into innovation-led strategic hubs * Proposed outsourcing tax could threaten service exports By Sai Ishwarbharath B, Haripriya Suresh and Rishika Sadam BENGALURU/HYDERABAD, Sept 30 (Reuters) - Donald Trump's H-1B visa crackdown will hasten U.S. firms' shift of...

COLUMN-Big Oil is long-term bullish despite short-term gloom: Bousso

Sep 29, 2025

(The opinions expressed here are those of the author, a columnist for Reuters.) * Oil majors cut buybacks and costs in face of expected downturn * But boards invest in big-ticket mega oil and gas projects * Oil supply growth expected to go into reverse by 2030 By Ron Bousso LONDON, Sept 30 (Reuters) - While energy companies are retrenching...

Trump visa curbs push U.S. firms to consider shifting more work to India

Sep 29, 2025

By Sai Ishwarbharath B, Haripriya Suresh and Rishika Sadam BENGALURU/HYDERABAD (Reuters) -Donald Trump's H-1B visa crackdown will hasten U.S. firms' shift of critical work to India, turbocharging the growth of global capability centres (GCCs) that handle operations from finance to research and development, economists and industry insiders say. The world's fifth-largest economy is home to 1,700 GCCs, or more than...

Coty launches strategic review of consumer beauty business

Sep 29, 2025

Sept 30 (Reuters) - Cosmetics-maker Coty ( COTY ) on Tuesday said it has launched a comprehensive strategic review of its consumer beauty business. ...